ATE339426T1 - Arylborsäuren für die behandlung von fettsucht - Google Patents

Arylborsäuren für die behandlung von fettsucht

Info

Publication number
ATE339426T1
ATE339426T1 AT02746808T AT02746808T ATE339426T1 AT E339426 T1 ATE339426 T1 AT E339426T1 AT 02746808 T AT02746808 T AT 02746808T AT 02746808 T AT02746808 T AT 02746808T AT E339426 T1 ATE339426 T1 AT E339426T1
Authority
AT
Austria
Prior art keywords
sub
substituted
sup
group
optionally
Prior art date
Application number
AT02746808T
Other languages
English (en)
Inventor
Stephen Randall Holmes-Farley
W Harry Mandeville Iii
Chad Cori Huval
Xinhua Li
Pradeep K Dhal
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE339426T1 publication Critical patent/ATE339426T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02746808T 2001-06-29 2002-07-01 Arylborsäuren für die behandlung von fettsucht ATE339426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30208101P 2001-06-29 2001-06-29
US35946702P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
ATE339426T1 true ATE339426T1 (de) 2006-10-15

Family

ID=26972758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746808T ATE339426T1 (de) 2001-06-29 2002-07-01 Arylborsäuren für die behandlung von fettsucht

Country Status (13)

Country Link
US (3) US6858592B2 (de)
EP (1) EP1404685B1 (de)
JP (1) JP2004535452A (de)
AT (1) ATE339426T1 (de)
AU (2) AU2002316499B2 (de)
CA (1) CA2489681A1 (de)
CY (1) CY1105829T1 (de)
DE (1) DE60214713T2 (de)
DK (1) DK1404685T3 (de)
ES (1) ES2275888T3 (de)
HK (1) HK1065046A1 (de)
PT (1) PT1404685E (de)
WO (1) WO2003002570A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
WO2003105860A1 (en) * 2002-06-14 2003-12-24 Novo Nordisk A/S Pharmaceutical use of boronic acids and esters thereof
WO2004046211A1 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
EP1824861A2 (de) * 2004-11-12 2007-08-29 Trustees of the Tufts College Lipaseinhibitoren
US7696347B2 (en) * 2005-03-14 2010-04-13 Eisai R&D Management Co., Ltd. Oxymethyl boron compounds
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
US10157355B2 (en) 2005-11-15 2018-12-18 General Electric Company Method to view schedule interdependencies and provide proactive clinical process decision support in day view form
US7801058B2 (en) * 2006-07-27 2010-09-21 Mobitrum Corporation Method and system for dynamic information exchange on mesh network devices
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
US8574546B2 (en) * 2007-07-24 2013-11-05 The University Of British Columbia Substituted aryl-fluoroborates as imaging agents
JP5637982B2 (ja) * 2008-04-09 2014-12-10 インフィニティー ファーマシューティカルズ， インコーポレイテッド 脂肪酸アミド加水分解酵素の阻害剤
CA2757679A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8541581B2 (en) 2009-04-07 2013-09-24 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
US8709489B2 (en) 2009-09-30 2014-04-29 Surmodics, Inc. Emulsions containing arylboronic acids and medical articles made therefrom
MX361692B (es) 2010-02-03 2018-12-13 Infinity Pharmaceuticals Inc Inhibidores de amida hidrolasa de ácido graso.
US8546617B1 (en) 2012-03-23 2013-10-01 Empire Technology Development Llc Dioxaborinanes and uses thereof
WO2014021845A1 (en) * 2012-07-31 2014-02-06 Empire Technology Development Llc Polymerizable organoboron alkyd resin anti fouling coatings
US9120938B2 (en) 2012-07-31 2015-09-01 Empire Technology Development Llc Polymerizable organoboron alkyd resin anti fouling coatings
EP2909216B1 (de) * 2012-10-17 2016-12-21 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College Zusammensetzungen und verfahren zur verbesserung der glucoseaufnahme
US10556023B2 (en) 2013-03-08 2020-02-11 The University Of British Columbia Substituted organofluoroborates as imaging agents
US11078528B2 (en) 2015-10-12 2021-08-03 Advanced Cell Diagnostics, Inc. In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
CN106243343B (zh) * 2016-08-11 2018-04-03 江苏大学 一种苯硼酸功能化嵌段聚合物的合成及应用
WO2022204368A1 (en) * 2021-03-24 2022-09-29 Trustees Of Tufts College Boronic acid compounds, compositions and methods

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496722A (en) * 1981-05-01 1985-01-29 The Children's Medical Center Corporation Reporter compounds
GB8819224D0 (en) 1988-08-12 1988-09-14 Merck Patent Gmbh Process for preparation of rod-like compounds
DE3930663C1 (en) 1989-09-14 1990-11-15 Merck Patent Gmbh, 6100 Darmstadt, De Cross-coupling metal organic cpds. and e.g. halogen cpds. - includes using transition metal-palladium catalyst and opt. metal alcoholate
EP0478050A1 (de) 1990-09-24 1992-04-01 Unilever N.V. Detergentzusammensetzung
GB9024775D0 (en) 1990-11-14 1991-01-02 Axis Research Chemical compounds
IE914573A1 (en) 1991-01-17 1992-07-29 Ici Plc Boron compounds
WO1992019707A1 (en) * 1991-04-30 1992-11-12 The Procter & Gamble Company Liquid detergents with an aryl boronic acid
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
CH683522A5 (de) 1992-03-13 1994-03-31 Hoffmann La Roche Verfahren zur Herstellung von Diarylen.
JP3257029B2 (ja) 1992-04-22 2002-02-18 日本油脂株式会社 フェニルボロン酸誘導体及び製造方法
CA2096496A1 (en) 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5290817A (en) * 1992-06-09 1994-03-01 The Du Pont Merck Pharmaceutical Co. Substituted 1-benzylindanes and their use as inhibitors of phospholipase A2
AU5708694A (en) 1992-12-21 1994-07-19 Zeneca Limited Quinuclidine derivatives as squalene synthase inhibitors
GB2276162A (en) 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benazilide derivatives
HUT73813A (en) 1993-06-30 1996-09-30 Wellcome Found Anti-athero-sclerotic diaryl compounds, process to prepare them and pharmaceutical compositions contg. them
CN1127014A (zh) * 1993-07-09 1996-07-17 诺沃挪第克公司 作为酶稳定剂的一烃基硼酸或二烃基硼酸衍生物
JP3412198B2 (ja) * 1993-08-31 2003-06-03 日本油脂株式会社 変性マレイン酸共重合体および用途
EP0724580A1 (de) 1993-10-19 1996-08-07 Smithkline Beecham Plc Benzamilid-derivate als 5ht-1d-rezeptor antagonisten
DK0741693T3 (da) * 1994-01-27 1999-10-11 Novartis Ag Fremgangsmåde og apparat til fremstilling af kontaktlinser
US5631364A (en) 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
SI9400289A (en) 1994-07-13 1996-02-29 Ponikvar Jadranka Buturovic A method for preventing blood coagulation in a haemodialysis circuit or haemodialysis analogy procedure in the extra-body circuit.
EP0796252A4 (de) 1994-12-09 1998-02-04 Smithkline Beecham Corp Bicyclische fibrinogen antagonisten
JPH10511855A (ja) 1995-01-09 1998-11-17 ノボ ノルディスク アクティーゼルスカブ 液体酵素組成物の安定化
EP0817767B1 (de) 1995-03-27 2000-05-24 Smithkline Beecham Plc Bicyclische amin-derivate und ihre verwendung als antipsychotische wirkstoffe
UA58494C2 (uk) 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
DE69621131T2 (de) * 1995-06-13 2002-11-28 Novozymes As 4-substituierte-phenylboronsäuren als enzymstabilisatoren
US5631371A (en) * 1995-11-22 1997-05-20 Bayer Corporation Method for the preparation of substituted 3-(phenylimino)-3H-phenothiazines and phenoxazines
GB9603137D0 (en) 1996-02-15 1996-04-17 Merck Sharp & Dohme Therapeutic agents
WO1998022820A1 (en) 1996-11-21 1998-05-28 Lawrence Livermore National Laboratory Detection of biological molecules using boronate-based chemical amplification and optical sensors
CA2288172A1 (en) 1997-04-18 1998-10-29 Smithkline Beecham P.L.C. A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
US6075014A (en) 1997-06-13 2000-06-13 Northwestern University Inhibitors of β-lactamases and uses therefor
US6184363B1 (en) * 1997-06-13 2001-02-06 Northwestern University Inhibitors of β-lactamases and uses therefor
JP2002510328A (ja) 1997-07-25 2002-04-02 スミスクライン・ビーチャム・コーポレイション ビトロネクチン受容体アンタゴニスト
CO5011067A1 (es) 1997-11-03 2001-02-28 Novartis Ag Derivados de bifenilo como productos farmaceuticos, su pre- paracion y composiciones farmaceuticas que los contienen
US6264937B1 (en) * 1998-01-09 2001-07-24 Geltex Pharmaceuticals, Inc. Fat-binding polymers
CA2321791A1 (en) 1998-03-18 1999-09-23 Ciba Specialty Chemicals Holding Inc. Coupling reactions with palladium catalysts
AU5235599A (en) 1998-07-31 2000-02-21 Eli Lilly And Company N-substituted sulfonamide derivatives
US6458829B1 (en) 1998-09-09 2002-10-01 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase
GB9824579D0 (en) 1998-11-10 1999-01-06 Novartis Ag Organic compounds
DE19857765A1 (de) * 1998-12-15 2000-06-21 Clariant Gmbh Verfahren zur Herstellung von para-Oxadiazolyl-phenyl-boronsäuren
WO2000035904A1 (en) 1998-12-16 2000-06-22 Northwestern University INHIBITORS OF β-LACTAMASES AND USES THEREFOR
AU3208200A (en) 1999-01-13 2000-08-01 Research Foundation Of The State University Of New York, The A novel method for designing protein kinase inhibitors
BRPI0011172B8 (pt) 1999-04-14 2021-05-25 Pacific Corp derivados do 4,5-diaril-3(2h)-furanona como inibidores de ciclooxigenase-2
JP4507294B2 (ja) 1999-05-27 2010-07-21 チッソ株式会社 ビアリール誘導体の製造方法
CA2315614C (en) 1999-07-29 2004-11-02 Pfizer Inc. Pyrazoles
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CN1285601C (zh) 2000-11-30 2006-11-22 佳能株式会社 发光器件和显示器
JP3589450B2 (ja) 2001-03-13 2004-11-17 独立行政法人 科学技術振興機構 アミド脱水縮合触媒として有用なパーフルオロアルキルフェニルホウ酸
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
AU2003243594A1 (en) 2002-06-13 2003-12-31 Johns Hopkins University Novel boronic chalcone derivatives and uses thereof
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids

Also Published As

Publication number Publication date
AU2002316499B2 (en) 2005-08-04
CA2489681A1 (en) 2003-01-09
US20050107336A1 (en) 2005-05-19
US7456156B2 (en) 2008-11-25
DK1404685T3 (da) 2007-01-22
US7049304B2 (en) 2006-05-23
AU2005220192A1 (en) 2005-12-01
WO2003002570A1 (en) 2003-01-09
DE60214713T2 (de) 2007-09-06
EP1404685A1 (de) 2004-04-07
PT1404685E (pt) 2007-01-31
ES2275888T3 (es) 2007-06-16
JP2004535452A (ja) 2004-11-25
CY1105829T1 (el) 2011-02-02
US20030064963A1 (en) 2003-04-03
DE60214713D1 (de) 2006-10-26
US6858592B2 (en) 2005-02-22
EP1404685B1 (de) 2006-09-13
HK1065046A1 (en) 2005-02-08
US20060128664A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE339426T1 (de) Arylborsäuren für die behandlung von fettsucht
CA2462085A1 (en) Cytotoxic agents
KR940003969A (ko) 피이지(peg)- 인터페론 결합체
EP0394989A3 (de) Peptidverbindungen, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten
CA2426885A1 (en) Complexes of phosphate derivatives
KR920700205A (ko) 트리-아자 마크로싸이클 화합물과 이들의 금속착화합물
EP2253330A3 (de) Biologische Konjugatmoleküle und ihre Herstellung
WO1997003106A1 (en) Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
RU2004127136A (ru) Способ получения гамма-амидов глутамовой кислоты
DE3769676D1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
ES8503666A1 (es) Procedimiento para la preparacion de 1-ariloxi-2,3,4,5-tetrahidro-3-benzazepinas
PT77110B (fr) Procede de preparation de nouveaux derives de la xanthine
TW332812B (en) A preparing process for phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups
DE69529624D1 (de) Neue endiyn-chinonimine und verfahren zu deren herstellung und verwendung
RU94002329A (ru) Модифицированные олигодезоксирибонуклеотиды, композиция, способ лечения и промежуточные соединения
EA200100969A1 (ru) Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции
JP2004534887A5 (de)
EP1264833A3 (de) 1,2-Phenylendiboronsaure Reagenzien und Komplexe
KR910014344A (ko) 베타-치환 술폰산 및/또는 술포네이트 및 그의 제조방법
RU99109978A (ru) Бис(акридинкарбоксамид) и бис(феназинкарбоксамид), полезные в качестве противоопухолевых агентов
CA2334980A1 (en) Method for separation on cation exchangers
DK1047658T3 (da) Fremgangsmåde til fremstilling af alkoxylerede dimerfedtsyrer
RU2002113661A (ru) Пролекарства 6-метокси-2-нафтилуксусной кислоты
CA2452920A1 (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
RU93033697A (ru) Производные 2-амино-n-[[[4-(аминокарбонил) пиримидин-2-ил]амино] алкил] пиримидин-4-карбоксамида, способ их получения и фармацевтическая композиция на их основе

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404685

Country of ref document: EP

REN Ceased due to non-payment of the annual fee